Hawaii’s public‑health agencies have raised an alert over cychlorphine, an illegal synthetic opioid that is reportedly up to ten times more potent than fentanyl. The drug has already been linked to multiple deaths in several states and officials say it is only a matter of time before fatalities occur in the islands.
Drug profile and national impact
Cychlorphine is a laboratory‑produced opioid first identified on the U.S. East Coast two years ago before spreading westward. According to the Drug Enforcement Administration, its potency can exceed that of fentanyl by a factor of ten. Since its emergence, the substance has been detected in California, Texas, Louisiana, Missouri, Tennessee, North Carolina, Ohio, Pennsylvania, New Hampshire and Nevada, with some jurisdictions reporting double‑digit death tolls.
The most recent high‑profile case involved a 16‑year‑old in San Francisco who died after ingesting counterfeit pills laced with cychlorphine. Police arrested four suspected dealers in connection with that overdose, underscoring the drug’s presence in the illicit market.
Hawaii’s response
Gary Yabuta, a representative of the Hawaii High‑Intensity Drug Trafficking Area (HIDTA) program, explained that the islands typically lag two years behind mainland trends. “Sooner or later, it’s going to be here,” Yabuta said, noting that the synthetic opioid was first identified on the East Coast before moving west.
In anticipation of local cases, the Honolulu Medical Examiner’s office, led by Dr. Masahiko Kobayashi, has asked the state’s toxicology laboratory (NMS) to place cychlorphine on its red‑alert list. Dr. James Ireland of the Honolulu Emergency Services Department emphasized the drug’s illegality and danger, stating, “We really don’t want people to die, especially young kids who are experimenting with drugs, maybe even for the first time.”
Treatment challenges and law‑enforcement hurdles
Naloxone, commonly known as Narcan, remains the primary antidote for opioid overdose. However, experts warn that a single dose may be insufficient for cychlorphine because of its extreme strength. Ireland explained that while naloxone “starts the therapy,” patients often require the injectable formulation carried by paramedics, and immediate administration is critical.
Law‑enforcement officials also face diagnostic obstacles. Field drug tests cannot reliably differentiate cychlorphine from other fentanyl analogues, meaning first responders may experience delays before confirming its presence in a suspected overdose.
DEA special agent Jae Chung, based in Atlanta, cautioned that purchasing any opioid outside legitimate medical channels is akin to “playing Russian roulette with your life.” The street version of cychlorphine is reportedly being sold through social‑media apps and disguised as prescription drugs such as Adderall and oxycodone.
Authorities advise anyone who suspects an opioid overdose to call 911 immediately and, if available, administer Narcan while awaiting emergency personnel. The combined efforts of Hawaii’s health officials, medical examiners and federal agents aim to curb the spread of cychlorphine before it claims lives on the islands.
Steve Lopez is a Senior Editorial Columnist and Health & Public Policy reporter for News Raise. Steve focuses on healthcare advancements, medical technologies, and public health policies.
